Neelapu, S. S., Chavez, J. C., Sehgal, A. R., Epperla, N., Ulrickson, M., Bachy, E., . . . Jacobson, C. A. (2024). Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma (ZUMA-5). Blood, 143(6), 496. https://doi.org/10.1182/blood.2023021243
Citácia podle Chicago (17th ed.)Neelapu, Sattva S., et al. "Three-year Follow-up Analysis of Axicabtagene Ciloleucel in Relapsed/refractory Indolent Non-Hodgkin Lymphoma (ZUMA-5)." Blood 143, no. 6 (2024): 496. https://doi.org/10.1182/blood.2023021243.
Citácia podľa MLA (8th ed.)Neelapu, Sattva S., et al. "Three-year Follow-up Analysis of Axicabtagene Ciloleucel in Relapsed/refractory Indolent Non-Hodgkin Lymphoma (ZUMA-5)." Blood, vol. 143, no. 6, 2024, p. 496, https://doi.org/10.1182/blood.2023021243.